GIVOSIRAN SODIUM

GIVOSIRAN SODIUM was reported 1559 times

GIVOSIRAN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROCTOSIGMOIDOSCOPY 1 1.0000
1 PORPHYRINS URINE DECREASED 2 1.0000
2 PORPHYRIA ACUTE 495 0.3449
3 URINE PORPHOBILINOGEN INCREASED 5 0.2273
4 URINE DELTA AMINOLEVULINATE INCREASED 4 0.2222
5 PORPHYRINS URINE INCREASED 4 0.1905
6 COPROPORPHYRINOGEN INCREASED 1 0.1667
7 EXPOSURE TO TOBACCO 1 0.1111
8 PERIVENTRICULAR HAEMORRHAGE NEONATAL 1 0.1111
9 BLOOD HOMOCYSTEINE INCREASED 40 0.0930
10 CAST REMOVAL 1 0.0833
11 NEUROLOGICAL REHABILITATION 1 0.0625
12 SLIPPING RIB SYNDROME 2 0.0556
13 HYPERHOMOCYSTEINAEMIA 14 0.0534
14 UNADJUSTED DOSE ADMINISTERED 3 0.0441
15 PORPHYRIA 15 0.0390
16 BLOOD HOMOCYSTEINE ABNORMAL 1 0.0385
17 BOWEL OBSTRUCTION SURGERY 2 0.0364
18 INJECTION SITE MUSCLE ATROPHY 1 0.0312
19 PANCREAS DIVISUM 1 0.0278
20 CLINICAL DEATH 1 0.0192
21 ADVERSE EVENT FOLLOWING IMMUNISATION 1 0.0179
22 SLEEP STUDY ABNORMAL 1 0.0175
23 STEM CELL THERAPY 1 0.0169
24 FASTING 1 0.0133
25 FUNGAL CYSTITIS 1 0.0133
26 FAMILIAL PERIODIC PARALYSIS 3 0.0132
27 LIVER IRON CONCENTRATION INCREASED 1 0.0123
28 RENIN DECREASED 1 0.0118
29 MITOCHONDRIAL DNA MUTATION 1 0.0116
30 MEDICAL DEVICE SITE INJURY 1 0.0101
31 SUTURE REMOVAL 1 0.0093
32 LARYNGEAL SQUAMOUS CELL CARCINOMA 1 0.0093
33 SUPERIOR MESENTERIC ARTERY SYNDROME 2 0.0090
34 VITAMIN B6 DECREASED 2 0.0078
35 ULTRASOUND LIVER ABNORMAL 1 0.0066
36 UNEVALUABLE INVESTIGATION 1 0.0060
37 MULTISYSTEM INFLAMMATORY SYNDROME 1 0.0058
38 ANAEMIA OF PREGNANCY 1 0.0058
39 PRODUCT ADMINISTERED BY WRONG PERSON 2 0.0052
40 POSTOPERATIVE DELIRIUM 1 0.0051
41 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
42 HERNIA HIATUS REPAIR 1 0.0049
43 TRACHEOSTOMY MALFUNCTION 1 0.0048
44 PANCREATIC ENZYMES INCREASED 7 0.0048
45 PELVIC HAEMORRHAGE 1 0.0046
46 INTENTIONAL DOSE OMISSION 119 0.0042
47 PNEUMOTHORAX TRAUMATIC 1 0.0041
48 ARTERIAL THERAPEUTIC PROCEDURE 1 0.0041
49 PULMONARY RESECTION 1 0.0040
50 NEONATAL SEIZURE 1 0.0040
51 VAGUS NERVE DISORDER 1 0.0040
52 EPILEPTIC AURA 1 0.0039
53 GRIEF REACTION 2 0.0038
54 IRON OVERLOAD 4 0.0037
55 CATHETER SITE THROMBOSIS 1 0.0036
56 BULBAR PALSY 1 0.0036
57 CHOLESTEATOMA 1 0.0036
58 THYROID CANCER METASTATIC 1 0.0036
59 SHORTENED CERVIX 1 0.0034
60 CATHETER SITE CELLULITIS 1 0.0034
61 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 1 0.0033
62 HYPERINSULINAEMIA 1 0.0033
63 ADVERSE FOOD REACTION 3 0.0032
64 ALLERGY TO ARTHROPOD BITE 1 0.0031
65 NOROVIRUS TEST POSITIVE 1 0.0031
66 OSTEOTOMY 1 0.0031
67 DELIVERY 2 0.0030
68 CATHETER SITE BRUISE 1 0.0030
69 CYSTITIS BACTERIAL 1 0.0030
70 DRUG THERAPY 1 0.0029
71 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
72 SPINAL NERVE STIMULATOR IMPLANTATION 1 0.0029
73 GIARDIASIS 1 0.0029
74 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
75 SERUM SEROTONIN INCREASED 1 0.0028
76 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
77 CARCINOID SYNDROME 1 0.0028
78 AXILLARY VEIN THROMBOSIS 1 0.0027
79 LUMBAR PUNCTURE 1 0.0026
80 DEPENDENCE ON RESPIRATOR 1 0.0025
81 INTESTINAL PROLAPSE 1 0.0024
82 COLONOSCOPY ABNORMAL 1 0.0023
83 PORPHYRIA NON-ACUTE 1 0.0023
84 NITRITE URINE PRESENT 1 0.0023
85 DIVORCED 1 0.0023
86 FEEDING INTOLERANCE 1 0.0022
87 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
88 BLOOD IRON ABNORMAL 2 0.0020
89 DRUG EXPOSURE BEFORE PREGNANCY 2 0.0020
90 BREAST CONSERVING SURGERY 1 0.0020
91 HYPERLIPASAEMIA 1 0.0019
92 ENZYME ABNORMALITY 1 0.0019
93 HYPERAMYLASAEMIA 1 0.0018
94 OEDEMATOUS PANCREATITIS 1 0.0018
95 NAIL INJURY 1 0.0018
96 ENTERAL NUTRITION 1 0.0017
97 DIAPHRAGMATIC PARALYSIS 1 0.0017
98 FAT NECROSIS 1 0.0016
99 PROSTATE CANCER RECURRENT 1 0.0016
100 CORTISOL INCREASED 1 0.0016
101 THIRST DECREASED 1 0.0016
102 TOXIC SHOCK SYNDROME 1 0.0016
103 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
104 ABDOMINAL OPERATION 2 0.0015
105 POSTOPERATIVE ADHESION 1 0.0015
106 PERSONAL RELATIONSHIP ISSUE 1 0.0015
107 TRIPLE NEGATIVE BREAST CANCER 1 0.0015
108 QUADRIPLEGIA 3 0.0015
109 THERAPY INTERRUPTED 103 0.0014
110 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
111 CULTURE URINE POSITIVE 2 0.0014
112 BLOOD OESTROGEN DECREASED 1 0.0014
113 BLOOD FOLATE DECREASED 1 0.0014
114 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
115 AMINO ACID LEVEL INCREASED 1 0.0013
116 ARTERIAL INJURY 1 0.0013
117 COMPLICATION OF PREGNANCY 1 0.0013
118 RENAL FUNCTION TEST ABNORMAL 6 0.0013
119 PRE-EXISTING CONDITION IMPROVED 8 0.0013
120 BLISTER INFECTED 1 0.0013
121 GALLBLADDER POLYP 1 0.0013
122 PRODUCT INEFFECTIVE 1 0.0013
123 INFANTILE APNOEA 1 0.0012
124 INJECTION SITE ATROPHY 2 0.0012
125 LEUKOCYTURIA 1 0.0012
126 ADRENAL MASS 1 0.0012
127 COVID-19 IMMUNISATION 1 0.0012
128 TWIN PREGNANCY 1 0.0012
129 HOSPITALISATION 182 0.0012
130 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
131 HEPATIC HAEMORRHAGE 1 0.0012
132 FOOD REFUSAL 1 0.0011
133 CATHETER SITE PRURITUS 1 0.0011
134 LIVER FUNCTION TEST INCREASED 24 0.0011
135 SELECTIVE EATING DISORDER 1 0.0011
136 CERUMEN IMPACTION 1 0.0011
137 THERAPEUTIC RESPONSE DELAYED 3 0.0011
138 WRIST SURGERY 1 0.0011
139 BLOOD IRON INCREASED 2 0.0011
140 OVARIAN DISORDER 1 0.0011
141 CATHETER SITE INFECTION 4 0.0011
142 ILL-DEFINED DISORDER 64 0.0011
143 LYMPHADENECTOMY 1 0.0010
144 DIPLEGIA 2 0.0010
145 CARDIAC ANEURYSM 1 0.0010
146 PSYCHOTIC BEHAVIOUR 1 0.0010
147 UTERINE CONTRACTIONS DURING PREGNANCY 1 0.0010
148 RESPIRATORY TRACT IRRITATION 1 0.0010
149 SINUSITIS BACTERIAL 1 0.0009
150 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
151 INNER EAR DISORDER 1 0.0009
152 BLOOD TESTOSTERONE INCREASED 2 0.0009
153 GALLBLADDER ENLARGEMENT 1 0.0009
154 SOMATIC SYMPTOM DISORDER 1 0.0009
155 INJECTION SITE INDENTATION 2 0.0009
156 BLADDER DILATATION 1 0.0009
157 ACINETOBACTER INFECTION 1 0.0009
158 DEAFNESS NEUROSENSORY 3 0.0009
159 STRESS AT WORK 1 0.0009
160 ADMINISTRATION SITE PAIN 1 0.0009
161 NECK SURGERY 2 0.0009
162 ENERGY INCREASED 5 0.0008
163 FULL BLOOD COUNT INCREASED 1 0.0008
164 HAEMATOMA MUSCLE 1 0.0008
165 BLADDER PROLAPSE 1 0.0008
166 POST-ACUTE COVID-19 SYNDROME 1 0.0008
167 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
168 ENCEPHALITIS AUTOIMMUNE 1 0.0008
169 ISCHAEMIC HEPATITIS 1 0.0007
170 VIRAEMIA 1 0.0007
171 THERAPEUTIC PROCEDURE 1 0.0007
172 PRERENAL FAILURE 1 0.0007
173 APPENDIX DISORDER 1 0.0007
174 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
175 BLOOD ELECTROLYTES DECREASED 1 0.0007
176 TRACHEOSTOMY 1 0.0007
177 NAIL INFECTION 1 0.0007
178 INVESTIGATION ABNORMAL 1 0.0007
179 VITAMIN B12 DECREASED 2 0.0007
180 VASCULAR INJURY 1 0.0007
181 PRECANCEROUS SKIN LESION 1 0.0007
182 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
183 HEART VALVE REPLACEMENT 1 0.0007
184 PITUITARY TUMOUR 1 0.0007
185 WEIGHT FLUCTUATION 7 0.0007
186 CENTRAL VENOUS CATHETERISATION 2 0.0007
187 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
188 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
189 LIPASE INCREASED 5 0.0007
190 RECTAL CANCER 2 0.0007
191 UNEVALUABLE EVENT 49 0.0006
192 PRODUCT DISTRIBUTION ISSUE 6 0.0006
193 INJECTION SITE DISCOLOURATION 8 0.0006
194 BRAIN FOG 10 0.0006
195 MEDICAL DEVICE IMPLANTATION 1 0.0006
196 NEONATAL DISORDER 1 0.0006
197 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
198 HORMONE LEVEL ABNORMAL 3 0.0006
199 SHOULDER FRACTURE 1 0.0006
200 SPLENIC RUPTURE 1 0.0006
201 SYSTEMIC INFECTION 1 0.0006
202 VENA CAVA THROMBOSIS 1 0.0006
203 ARTHROPOD STING 1 0.0006
204 FOOD AVERSION 1 0.0006
205 SLEEP TALKING 1 0.0006
206 RESPIRATION ABNORMAL 4 0.0006
207 AMYLOIDOSIS 1 0.0006
208 SERUM FERRITIN DECREASED 1 0.0006
209 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
210 TREATMENT DELAYED 1 0.0006
211 HYSTERECTOMY 5 0.0006
212 MASTECTOMY 1 0.0006
213 GASTROINTESTINAL OEDEMA 1 0.0006
214 FEAR OF DISEASE 1 0.0006
215 SEIZURE 64 0.0006
216 RENAL TRANSPLANT 2 0.0006
217 NASAL OEDEMA 1 0.0006
218 MONOPARESIS 1 0.0006
219 LIVER TRANSPLANT 2 0.0005
220 FOOD INTOLERANCE 2 0.0005
221 BODY TEMPERATURE ABNORMAL 1 0.0005
222 OESOPHAGEAL SPASM 1 0.0005
223 DISORGANISED SPEECH 1 0.0005
224 AMYLASE INCREASED 2 0.0005
225 DENTAL CARE 1 0.0005
226 CATHETER PLACEMENT 1 0.0005
227 INJECTION SITE CELLULITIS 1 0.0005
228 AURA 1 0.0005
229 TUNNEL VISION 1 0.0005
230 NARCOLEPSY 1 0.0005
231 ADVERSE REACTION 7 0.0005
232 MECHANICAL VENTILATION 1 0.0005
233 ARTERIAL DISORDER 1 0.0005
234 PANCREATIC CYST 1 0.0005
235 ADRENAL DISORDER 1 0.0005
236 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
237 ATROPHY 1 0.0005
238 INJECTION SITE NECROSIS 1 0.0005
239 WALKING DISABILITY 1 0.0005
240 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
241 FOETAL DISTRESS SYNDROME 1 0.0005
242 RENAL NEOPLASM 1 0.0005
243 ANAEMIA MACROCYTIC 1 0.0005
244 HEPATIC PAIN 2 0.0005
245 INCOHERENT 3 0.0005
246 INFUSION SITE BRUISING 1 0.0005
247 COLONOSCOPY 1 0.0005
248 NOSOCOMIAL INFECTION 1 0.0005
249 ACCIDENT AT WORK 1 0.0005
250 APPETITE DISORDER 3 0.0005
251 FAECES PALE 1 0.0004
252 HYPERTENSIVE CRISIS 5 0.0004
253 PARESIS 1 0.0004
254 CHOLESTATIC LIVER INJURY 1 0.0004
255 CALCINOSIS 1 0.0004
256 LARGE INTESTINAL OBSTRUCTION 1 0.0004
257 FEAR OF DEATH 1 0.0004
258 ABNORMAL LOSS OF WEIGHT 3 0.0004
259 BRAIN OPERATION 1 0.0004
260 ILLNESS 45 0.0004
261 UTERINE DISORDER 1 0.0004
262 DIALYSIS 6 0.0004
263 VOLVULUS 1 0.0004
264 PARALYSIS 6 0.0004
265 GASTROINTESTINAL OBSTRUCTION 1 0.0004
266 SELF ESTEEM DECREASED 1 0.0004
267 NEURALGIA 10 0.0004
268 DERMAL CYST 1 0.0004
269 GASTROINTESTINAL TUBE INSERTION 1 0.0004
270 VEIN DISORDER 2 0.0004
271 PREGNANCY 8 0.0004
272 PRODUCT DOSE OMISSION ISSUE 117 0.0004
273 INCREASED BRONCHIAL SECRETION 1 0.0004
274 MENOPAUSE 1 0.0004
275 POOR VENOUS ACCESS 4 0.0004
276 LIPOMA 1 0.0004
277 CATHETER SITE PAIN 1 0.0004
278 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
279 FOOD CRAVING 2 0.0004
280 SERUM FERRITIN INCREASED 2 0.0004
281 RENAL PAIN 4 0.0004
282 ABDOMINAL MASS 1 0.0004
283 BLOOD PHOSPHORUS INCREASED 1 0.0004
284 ASPIRATION 4 0.0004
285 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
286 PANCREATITIS 19 0.0004
287 HEART RATE ABNORMAL 2 0.0004
288 KIDNEY INFECTION 7 0.0004
289 PRODUCT LEAKAGE 2 0.0004
290 BREAST CANCER STAGE IV 1 0.0004
291 BLOOD CREATININE INCREASED 23 0.0004
292 CHOLECYSTECTOMY 4 0.0003
293 NEUROLOGICAL SYMPTOM 2 0.0003
294 HEART VALVE INCOMPETENCE 1 0.0003
295 BLOOD MAGNESIUM DECREASED 3 0.0003
296 FIBULA FRACTURE 1 0.0003
297 PARAPLEGIA 1 0.0003
298 MENTAL DISORDER 15 0.0003
299 ABORTION 1 0.0003
300 PULMONARY PAIN 1 0.0003
301 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
302 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
303 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
304 NECK INJURY 1 0.0003
305 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
306 ACNE CYSTIC 1 0.0003
307 EMBOLISM VENOUS 1 0.0003
308 DYSCHEZIA 1 0.0003
309 ECTOPIC PREGNANCY 1 0.0003
310 PERSONALITY CHANGE 3 0.0003
311 APPENDICITIS 3 0.0003
312 INJECTION SITE HYPERSENSITIVITY 1 0.0003
313 BLADDER PAIN 1 0.0003
314 POLYMYALGIA RHEUMATICA 1 0.0003
315 HYPERSOMNIA 9 0.0003
316 ABDOMINAL PAIN 73 0.0003
317 PNEUMONIA VIRAL 1 0.0003
318 CHROMATURIA 7 0.0003
319 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
320 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
321 LABORATORY TEST ABNORMAL 9 0.0003
322 SOMNAMBULISM 2 0.0003
323 WALKING AID USER 2 0.0003
324 SUSPECTED COVID-19 1 0.0003
325 PHOTOSENSITIVITY REACTION 5 0.0003
326 PRESCRIBED UNDERDOSE 6 0.0003
327 NEPHRITIS 1 0.0003
328 POTENTIATING DRUG INTERACTION 1 0.0003
329 HEPATIC FIBROSIS 1 0.0003
330 TEMPERATURE INTOLERANCE 3 0.0003
331 CERVICAL VERTEBRAL FRACTURE 1 0.0003
332 INJECTION SITE DISCOMFORT 3 0.0003
333 NECROTISING FASCIITIS 1 0.0003
334 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
335 APPENDICECTOMY 1 0.0003
336 ADVERSE DRUG REACTION 25 0.0003
337 PHARYNGITIS STREPTOCOCCAL 3 0.0003
338 BLOOD GLUCOSE FLUCTUATION 3 0.0003
339 HYPOMANIA 1 0.0003
340 ARTHROPOD BITE 2 0.0003
341 TRANSAMINASES INCREASED 6 0.0003
342 TENDON INJURY 1 0.0003
343 HYPERACUSIS 1 0.0003
344 SUNBURN 2 0.0003
345 MALNUTRITION 3 0.0003
346 PANCREATITIS ACUTE 6 0.0003
347 CHEMOTHERAPY 1 0.0003
348 HEPATIC ENZYME INCREASED 18 0.0003
349 RENAL IMPAIRMENT 22 0.0003
350 CLAVICLE FRACTURE 1 0.0003
351 PROCEDURAL COMPLICATION 2 0.0003
352 THYROID MASS 1 0.0003
353 DEVICE RELATED INFECTION 4 0.0003
354 ANKLE FRACTURE 4 0.0003
355 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
356 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
357 DELUSION 4 0.0003
358 PELVIC FRACTURE 2 0.0003
359 CARDIOPULMONARY FAILURE 1 0.0003
360 RENAL CYST 2 0.0003
361 HYPERPHAGIA 1 0.0003
362 POLYNEUROPATHY 3 0.0003
363 FOREIGN BODY 1 0.0002
364 INTRACRANIAL ANEURYSM 1 0.0002
365 GALLBLADDER OPERATION 1 0.0002
366 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
367 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
368 BLOOD POTASSIUM INCREASED 4 0.0002
369 POST PROCEDURAL INFECTION 2 0.0002
370 DECUBITUS ULCER 2 0.0002
371 PERIPHERAL VENOUS DISEASE 1 0.0002
372 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
373 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
374 HEPATIC FUNCTION ABNORMAL 9 0.0002
375 ONYCHOMADESIS 1 0.0002
376 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
377 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
378 EATING DISORDER 5 0.0002
379 HIATUS HERNIA 3 0.0002
380 HEPATIC LESION 1 0.0002
381 BONE CANCER 1 0.0002
382 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
383 IMMOBILE 1 0.0002
384 DYSPHEMIA 1 0.0002
385 BLOOD CREATINE INCREASED 1 0.0002
386 WHEELCHAIR USER 1 0.0002
387 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
388 ABORTION SPONTANEOUS 9 0.0002
389 SURGERY 13 0.0002
390 VASCULAR DEVICE INFECTION 1 0.0002
391 IMPAIRED GASTRIC EMPTYING 3 0.0002
392 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
393 DISEASE COMPLICATION 1 0.0002
394 LUMBAR VERTEBRAL FRACTURE 1 0.0002
395 COVID-19 38 0.0002
396 HUNGER 3 0.0002
397 TIBIA FRACTURE 1 0.0002
398 HEPATIC CIRRHOSIS 4 0.0002
399 PRE-ECLAMPSIA 1 0.0002
400 ENDOMETRIOSIS 1 0.0002
401 GAIT INABILITY 7 0.0002
402 KIDNEY TRANSPLANT REJECTION 1 0.0002
403 ENTEROCOCCAL INFECTION 1 0.0002
404 EAR PAIN 4 0.0002
405 PRESYNCOPE 5 0.0002
406 LIVER INJURY 5 0.0002
407 HEPATOMEGALY 2 0.0002
408 PANCREATIC DISORDER 1 0.0002
409 BREATH SOUNDS ABNORMAL 1 0.0002
410 FOOT OPERATION 1 0.0002
411 BLADDER DISORDER 2 0.0002
412 BLOOD PRESSURE ABNORMAL 4 0.0002
413 ANEURYSM 1 0.0002
414 HYPERNATRAEMIA 1 0.0002
415 HYPOTONIA 2 0.0002
416 BRAIN INJURY 2 0.0002
417 KLEBSIELLA INFECTION 1 0.0002
418 FEEDING DISORDER 4 0.0002
419 SLUGGISHNESS 2 0.0002
420 AMMONIA INCREASED 1 0.0002
421 PETIT MAL EPILEPSY 1 0.0002
422 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
423 TRISMUS 1 0.0002
424 FOETAL DEATH 1 0.0002
425 FAILURE TO THRIVE 1 0.0002
426 NERVOUS SYSTEM DISORDER 6 0.0002
427 NYSTAGMUS 1 0.0002
428 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
429 COMPRESSION FRACTURE 1 0.0002
430 INJECTION SITE DISCHARGE 1 0.0002
431 BIPOLAR DISORDER 2 0.0002
432 PULMONARY THROMBOSIS 2 0.0002
433 TIC 1 0.0002
434 FAECALOMA 1 0.0002
435 LIVER DISORDER 8 0.0002
436 NERVE INJURY 2 0.0002
437 BLOOD UREA INCREASED 3 0.0002
438 ORAL PAIN 4 0.0002
439 NEPHROPATHY TOXIC 2 0.0002
440 EYE INFECTION 2 0.0002
441 PERONEAL NERVE PALSY 1 0.0002
442 THERAPY CESSATION 9 0.0002
443 HYPERTONIA 1 0.0002
444 EXERCISE TOLERANCE DECREASED 1 0.0002
445 HERPES VIRUS INFECTION 1 0.0002
446 BLOOD URIC ACID INCREASED 1 0.0002
447 METABOLIC DISORDER 1 0.0002
448 RALES 1 0.0002
449 STRESS CARDIOMYOPATHY 1 0.0002
450 SPLENOMEGALY 2 0.0002
451 URINE ODOUR ABNORMAL 1 0.0002
452 DECREASED INTEREST 1 0.0002
453 COVID-19 PNEUMONIA 2 0.0002
454 AMNESIA 11 0.0002
455 MALAISE 74 0.0002
456 WEIGHT DECREASED 47 0.0002
457 PROTHROMBIN TIME PROLONGED 1 0.0002
458 SYMPTOM RECURRENCE 1 0.0002
459 WRIST FRACTURE 2 0.0002
460 HEPATIC FAILURE 5 0.0002
461 APHASIA 5 0.0002
462 TENSION 1 0.0002
463 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
464 LARYNGEAL OEDEMA 1 0.0002
465 CHOLANGITIS 1 0.0002
466 WEIGHT INCREASED 36 0.0002
467 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
468 HALLUCINATION 12 0.0002
469 MUSCLE ATROPHY 2 0.0002
470 INJECTION SITE IRRITATION 2 0.0002
471 SCREAMING 1 0.0002
472 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
473 ENTERITIS 1 0.0002
474 POST PROCEDURAL COMPLICATION 3 0.0002
475 LOSS OF CONSCIOUSNESS 20 0.0002
476 HYPERPROLACTINAEMIA 1 0.0002
477 PLATELET COUNT INCREASED 2 0.0002
478 NEPHROLITHIASIS 7 0.0002
479 BEDRIDDEN 2 0.0002
480 CORONAVIRUS INFECTION 1 0.0002
481 DYSMENORRHOEA 2 0.0002
482 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
483 RENAL DISORDER 7 0.0002
484 SKIN DISORDER 5 0.0001
485 PAIN 92 0.0001
486 SPINAL FRACTURE 3 0.0001
487 TERMINAL STATE 1 0.0001
488 POST-TRAUMATIC STRESS DISORDER 1 0.0001
489 NAUSEA 118 0.0001
490 METASTASES TO LYMPH NODES 1 0.0001
491 WRONG PRODUCT ADMINISTERED 1 0.0001
492 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
493 ACUTE HEPATIC FAILURE 2 0.0001
494 FEELING ABNORMAL 35 0.0001
495 MEMORY IMPAIRMENT 20 0.0001
496 HYPERTRANSAMINASAEMIA 1 0.0001
497 AUTOIMMUNE HEPATITIS 1 0.0001
498 FORMICATION 1 0.0001
499 DEMENTIA 4 0.0001
500 CARPAL TUNNEL SYNDROME 2 0.0001
501 VOMITING 67 0.0001
502 MOUTH ULCERATION 3 0.0001
503 BLOOD TEST ABNORMAL 2 0.0001
504 DEVICE OCCLUSION 2 0.0001
505 SKIN REACTION 2 0.0001
506 THERMAL BURN 1 0.0001
507 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
508 RETCHING 3 0.0001
509 FEAR OF INJECTION 1 0.0001
510 PANIC REACTION 1 0.0001
511 FAECES SOFT 1 0.0001
512 MAJOR DEPRESSION 1 0.0001
513 THROMBOSIS 11 0.0001
514 MIGRAINE 13 0.0001
515 DYSURIA 5 0.0001
516 PSYCHIATRIC SYMPTOM 1 0.0001
517 CEREBRAL DISORDER 1 0.0001
518 PAROSMIA 1 0.0001
519 FATIGUE 103 0.0001
520 PRODUCT AVAILABILITY ISSUE 3 0.0001
521 HEPATOCELLULAR CARCINOMA 1 0.0001
522 TROPONIN INCREASED 1 0.0001
523 INSURANCE ISSUE 2 0.0001
524 BOWEL MOVEMENT IRREGULARITY 1 0.0001
525 MUSCLE TWITCHING 3 0.0001
526 CONCUSSION 1 0.0001
527 PULMONARY HAEMORRHAGE 1 0.0001
528 DRUG-INDUCED LIVER INJURY 4 0.0001
529 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
530 AFFECTIVE DISORDER 1 0.0001
531 FURUNCLE 1 0.0001
532 PNEUMOTHORAX 2 0.0001
533 HALLUCINATION, AUDITORY 2 0.0001
534 BLOOD PRESSURE FLUCTUATION 3 0.0001
535 BLOOD DISORDER 1 0.0001
536 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
537 UTERINE CANCER 1 0.0001
538 SENSORY LOSS 1 0.0001
539 INJECTION SITE PAIN 38 0.0001
540 FRUSTRATION TOLERANCE DECREASED 1 0.0001
541 SHOCK HAEMORRHAGIC 1 0.0001
542 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
543 MENSTRUAL DISORDER 1 0.0001
544 ABDOMINAL PAIN LOWER 3 0.0001
545 CANDIDA INFECTION 2 0.0001
546 VITAMIN D DECREASED 1 0.0001
547 PSEUDOMONAS INFECTION 1 0.0001
548 SEPSIS 13 0.0001
549 CARDIAC OPERATION 1 0.0001
550 PSYCHOLOGICAL TRAUMA 1 0.0001
551 AMENORRHOEA 2 0.0001
552 GASTRITIS 3 0.0001
553 SPINAL OSTEOARTHRITIS 1 0.0001
554 IMMUNOSUPPRESSION 1 0.0001
555 SLEEP DISORDER 8 0.0001
556 RENAL FAILURE 15 0.0001
557 RESPIRATORY RATE INCREASED 1 0.0001
558 MOBILITY DECREASED 8 0.0001
559 HEAVY MENSTRUAL BLEEDING 1 0.0001
560 GASTROENTERITIS VIRAL 2 0.0001
561 OSTEOMYELITIS 2 0.0001
562 PATHOGEN RESISTANCE 1 0.0001
563 TREATMENT NONCOMPLIANCE 6 0.0001
564 PNEUMONIA BACTERIAL 1 0.0001
565 ABNORMAL DREAMS 3 0.0001
566 HEPATIC STEATOSIS 2 0.0001
567 BACTERIAL INFECTION 2 0.0001
568 ABDOMINAL PAIN UPPER 22 0.0001
569 FLANK PAIN 1 0.0001
570 PHOTOPHOBIA 2 0.0001
571 DYSARTHRIA 4 0.0001
572 ABORTION INDUCED 1 0.0001
573 INTESTINAL OBSTRUCTION 4 0.0001
574 BLOOD SODIUM DECREASED 2 0.0001
575 PAIN IN JAW 3 0.0001
576 SPINAL DISORDER 1 0.0001
577 FOOT FRACTURE 2 0.0001
578 GASTRIC ULCER 2 0.0001
579 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
580 NEUROPATHY PERIPHERAL 10 0.0001
581 DEHYDRATION 14 0.0001
582 SLEEP APNOEA SYNDROME 2 0.0001
583 INCREASED APPETITE 2 0.0001
584 MULTIPLE SCLEROSIS 5 0.0001
585 LETHARGY 6 0.0001
586 LOWER LIMB FRACTURE 2 0.0001
587 AFFECT LABILITY 1 0.0001
588 MUSCLE SPASMS 19 0.0001
589 VITAMIN D DEFICIENCY 1 0.0001
590 PHARYNGEAL SWELLING 1 0.0001
591 INJECTION SITE REACTION 7 0.0001
592 KNEE OPERATION 1 0.0001
593 HOSPICE CARE 1 0.0001
594 DISABILITY 2 0.0001
595 INABILITY TO AFFORD MEDICATION 1 0.0001
596 GASTROINTESTINAL DISORDER 9 0.0001
597 CONFUSIONAL STATE 16 0.0001
598 VAGINAL DISCHARGE 1 0.0001
599 INFLUENZA 11 0.0001
600 DYSKINESIA 4 0.0001
601 FLUID RETENTION 5 0.0001
602 EPILEPSY 3 0.0001
603 MOTOR DYSFUNCTION 1 0.0001
604 BODY TEMPERATURE INCREASED 2 0.0001
605 EMOTIONAL DISORDER 3 0.0001
606 INJECTION SITE ERYTHEMA 12 0.0001
607 ABDOMINAL DISTENSION 10 0.0001
608 NERVOUSNESS 5 0.0001
609 ROAD TRAFFIC ACCIDENT 4 0.0001
610 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
611 POOR QUALITY SLEEP 2 0.0001
612 DEPRESSION 21 0.0001
613 MENSTRUATION DELAYED 1 0.0001
614 CONDITION AGGRAVATED 28 0.0001
615 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
616 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
617 GASTROINTESTINAL PAIN 1 0.0001
618 ANAPHYLACTIC REACTION 5 0.0001
619 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
620 FOOT DEFORMITY 1 0.0001
621 URINARY RETENTION 3 0.0001
622 NEOPLASM MALIGNANT 6 0.0001
623 INJECTION SITE PRURITUS 6 0.0001
624 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
625 SKIN INFECTION 1 0.0001
626 MICTURITION URGENCY 1 0.0001
627 SUICIDAL IDEATION 8 0.0001
628 TINNITUS 4 0.0001
629 NEOPLASM 1 0.0001
630 HYPOAESTHESIA 13 0.0001
631 ELECTROLYTE IMBALANCE 1 0.0001
632 BURNING SENSATION 6 0.0001
633 SPINAL PAIN 1 0.0001
634 ANXIETY 24 0.0001
635 BACTERAEMIA 1 0.0001
636 CHOLECYSTITIS 1 0.0001
637 ACCIDENT 1 0.0001
638 BLOOD GLUCOSE DECREASED 4 0.0001
639 IRRITABILITY 5 0.0001
640 INFECTION 12 0.0001
641 LOCALISED INFECTION 2 0.0001
642 INSOMNIA 22 0.0001
643 CRYING 3 0.0001
644 ADRENAL INSUFFICIENCY 1 0.0001
645 URINARY TRACT INFECTION 14 0.0001
646 BACK PAIN 19 0.0001
647 RESPIRATORY DEPRESSION 1 0.0001
648 PAIN IN EXTREMITY 24 0.0001
649 MUSCLE SPASTICITY 1 0.0001
650 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
651 SMALL INTESTINAL OBSTRUCTION 1 0.0001
652 SPINAL OPERATION 1 0.0001
653 TOOTH EXTRACTION 1 0.0001
654 PNEUMONIA 26 0.0001
655 LEUKOPENIA 4 0.0001
656 ASTHENIA 30 0.0001
657 DERMATITIS ALLERGIC 1 0.0001
658 SOMNOLENCE 16 0.0001
659 CELLULITIS 4 0.0001
660 BRAIN OEDEMA 1 0.0001
661 HAEMATEMESIS 2 0.0001
662 TACHYCARDIA 7 0.0001
663 HEPATIC CYTOLYSIS 1 0.0001
664 TREMOR 13 0.0001
665 HEPATITIS 2 0.0001
666 FALL 26 0.0001
667 ROTATOR CUFF SYNDROME 1 0.0001
668 DECREASED APPETITE 18 0.0001
669 SKIN ULCER 2 0.0001
670 EXPOSURE VIA SKIN CONTACT 2 0.0001
671 INJECTION SITE INDURATION 1 0.0001
672 NODULE 1 0.0001
673 IMMUNE SYSTEM DISORDER 1 0.0001
674 TOOTH INFECTION 1 0.0001
675 PULMONARY CONGESTION 1 0.0001
676 SARS-COV-2 TEST POSITIVE 1 0.0001
677 DISORIENTATION 3 0.0001
678 PLATELET COUNT DECREASED 8 0.0001
679 PAIN OF SKIN 2 0.0001
680 DISTURBANCE IN ATTENTION 4 0.0001
681 BLOOD BILIRUBIN INCREASED 2 0.0001
682 PALLOR 2 0.0001
683 SKIN LESION 2 0.0001
684 PERIPHERAL COLDNESS 1 0.0001
685 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
686 ORAL DISCOMFORT 1 0.0001
687 ACUTE KIDNEY INJURY 11 0.0001
688 FEELING COLD 2 0.0001
689 NECK PAIN 4 0.0001
690 OXYGEN SATURATION DECREASED 4 0.0001
691 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
692 TARDIVE DYSKINESIA 2 0.0001
693 HEADACHE 44 0.0001
694 SYNCOPE 7 0.0001
695 PARAESTHESIA 11 0.0001
696 CARDIOGENIC SHOCK 1 0.0001
697 ACCIDENTAL UNDERDOSE 1 0.0001
698 PARAESTHESIA ORAL 1 0.0001
699 MYELODYSPLASTIC SYNDROME 1 0.0001
700 INJECTION SITE HAEMATOMA 1 0.0001
701 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
702 LIVER FUNCTION TEST ABNORMAL 2 0.0001
703 APATHY 1 0.0001
704 GASTROENTERITIS 1 0.0001
705 AGITATION 5 0.0001
706 GAIT DISTURBANCE 13 0.0001
707 RESPIRATORY DISORDER 2 0.0001
708 HYPOAESTHESIA ORAL 1 0.0001
709 DISCOMFORT 4 0.0001
710 BLOOD PRESSURE INCREASED 10 0.0001
711 INJECTION SITE SWELLING 5 0.0001
712 INJECTION SITE RASH 2 0.0001
713 ADVERSE EVENT 6 0.0001
714 MUSCULOSKELETAL CHEST PAIN 1 0.0001
715 TENDONITIS 1 0.0001
716 BLOOD CHOLESTEROL INCREASED 3 0.0001
717 COGNITIVE DISORDER 3 0.0001
718 CYANOSIS 1 0.0001
719 COMA 3 0.0001
720 CYSTITIS 2 0.0001
721 SENSORY DISTURBANCE 1 0.0001
722 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
723 MUSCLE TIGHTNESS 1 0.0001
724 MUSCULAR WEAKNESS 7 0.0001
725 BACK DISORDER 1 0.0001
726 INCORRECT DOSE ADMINISTERED 14 0.0001
727 CHOLELITHIASIS 2 0.0001
728 EYE DISORDER 2 0.0001
729 MANIA 1 0.0001
730 HEART RATE INCREASED 6 0.0001
731 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
732 LIP SWELLING 2 0.0001
733 ANGER 2 0.0001
734 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
735 PERIPHERAL SWELLING 9 0.0001
736 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
737 BALANCE DISORDER 5 0.0001
738 OEDEMA PERIPHERAL 7 0.0001
739 HYPOXIA 2 0.0001
740 HYPERTENSION 12 0.0001
741 LYMPHADENOPATHY 2 0.0001
742 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
743 ISCHAEMIC STROKE 1 0.0001
744 GALLBLADDER DISORDER 1 0.0001
745 CEREBRAL HAEMORRHAGE 2 0.0001
746 TOOTHACHE 1 0.0001
747 PELVIC PAIN 1 0.0001
748 RESTLESS LEGS SYNDROME 1 0.0001
749 PYREXIA 19 0.0001
750 PANIC ATTACK 2 0.0001
751 RESPIRATORY FAILURE 4 0.0001
752 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
753 BLOOD GLUCOSE ABNORMAL 1 0.0001
754 BRONCHITIS 4 0.0001
755 THINKING ABNORMAL 1 0.0001
756 MIDDLE INSOMNIA 1 0.0001
757 COUGH 15 0.0001
758 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
759 DYSPNOEA EXERTIONAL 2 0.0001
760 PULMONARY EMBOLISM 5 0.0001
761 PROTEINURIA 1 0.0001
762 CHOLESTASIS 1 0.0001
763 ACUTE RESPIRATORY FAILURE 1 0.0001
764 HERNIA 1 0.0001
765 CHOKING 1 0.0001
766 ARTHRITIS 4 0.0001
767 ABNORMAL BEHAVIOUR 2 0.0001
768 UPPER LIMB FRACTURE 1 0.0001
769 PRODUCT PHYSICAL ISSUE 1 0.0000
770 PRODUCT ADMINISTRATION ERROR 1 0.0000
771 TASTE DISORDER 1 0.0000
772 VERTIGO 3 0.0000
773 INJURY ASSOCIATED WITH DEVICE 1 0.0000
774 BLINDNESS 2 0.0000
775 CHEST DISCOMFORT 5 0.0000
776 NASOPHARYNGITIS 9 0.0000
777 RIB FRACTURE 1 0.0000
778 CHEST PAIN 9 0.0000
779 EXPOSURE DURING PREGNANCY 3 0.0000
780 TOOTH LOSS 1 0.0000
781 PULMONARY HYPERTENSION 1 0.0000
782 POLLAKIURIA 2 0.0000
783 KNEE ARTHROPLASTY 1 0.0000
784 HALLUCINATION, VISUAL 1 0.0000
785 CEREBROVASCULAR ACCIDENT 8 0.0000
786 OSTEOARTHRITIS 2 0.0000
787 MYALGIA 8 0.0000
788 JOINT INJURY 1 0.0000
789 DEEP VEIN THROMBOSIS 3 0.0000
790 DIZZINESS 23 0.0000
791 SWELLING FACE 3 0.0000
792 SEPTIC SHOCK 2 0.0000
793 PRODUCT PRESCRIBING ISSUE 1 0.0000
794 CONSTIPATION 10 0.0000
795 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
796 MELAENA 1 0.0000
797 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
798 TOOTH DISORDER 1 0.0000
799 HEPATOTOXICITY 1 0.0000
800 THROAT IRRITATION 2 0.0000
801 HEART RATE IRREGULAR 1 0.0000
802 NO ADVERSE EVENT 8 0.0000
803 SHOCK 1 0.0000
804 OROPHARYNGEAL PAIN 4 0.0000
805 BREAST CANCER 4 0.0000
806 ARRHYTHMIA 2 0.0000
807 ANAEMIA 8 0.0000
808 MENTAL IMPAIRMENT 1 0.0000
809 ENCEPHALOPATHY 1 0.0000
810 DYSPEPSIA 4 0.0000
811 PNEUMONIA ASPIRATION 1 0.0000
812 HOT FLUSH 3 0.0000
813 CHRONIC KIDNEY DISEASE 3 0.0000
814 DIABETES MELLITUS 3 0.0000
815 HYPOPHAGIA 1 0.0000
816 SINUSITIS 4 0.0000
817 DIPLOPIA 1 0.0000
818 RESPIRATORY TRACT INFECTION 1 0.0000
819 DRUG INTERACTION 6 0.0000
820 HYPERSENSITIVITY 7 0.0000
821 INJECTION SITE BRUISING 3 0.0000
822 EAR INFECTION 1 0.0000
823 THROAT TIGHTNESS 1 0.0000
824 LIMB INJURY 1 0.0000
825 INFLUENZA LIKE ILLNESS 3 0.0000
826 HAEMATOCHEZIA 2 0.0000
827 DIVERTICULITIS 1 0.0000
828 PROCEDURAL PAIN 1 0.0000
829 MENTAL STATUS CHANGES 1 0.0000
830 DEATH 31 0.0000
831 HAEMOPTYSIS 1 0.0000
832 DRUG INEFFECTIVE 47 0.0000
833 ALOPECIA 7 0.0000
834 BLISTER 2 0.0000
835 DYSPHONIA 2 0.0000
836 PALPITATIONS 4 0.0000
837 CHILLS 4 0.0000
838 ASCITES 1 0.0000
839 PSYCHOTIC DISORDER 1 0.0000
840 URINARY INCONTINENCE 1 0.0000
841 RENAL INJURY 1 0.0000
842 BLOOD POTASSIUM DECREASED 1 0.0000
843 PREMATURE BABY 1 0.0000
844 EMOTIONAL DISTRESS 4 0.0000
845 SUICIDE ATTEMPT 2 0.0000
846 LIMB DISCOMFORT 1 0.0000
847 FEMUR FRACTURE 1 0.0000
848 CARDIAC DISORDER 3 0.0000
849 SWELLING 3 0.0000
850 HEAD INJURY 1 0.0000
851 METABOLIC ACIDOSIS 1 0.0000
852 ARTHRALGIA 13 0.0000
853 PRURITUS 12 0.0000
854 HIP FRACTURE 1 0.0000
855 DRUG INTOLERANCE 3 0.0000
856 LACTIC ACIDOSIS 1 0.0000
857 ATRIAL FIBRILLATION 3 0.0000
858 STAPHYLOCOCCAL INFECTION 1 0.0000
859 VISUAL ACUITY REDUCED 1 0.0000
860 VIRAL INFECTION 1 0.0000
861 DYSPNOEA 17 0.0000
862 EYE PRURITUS 1 0.0000
863 TYPE 2 DIABETES MELLITUS 1 0.0000
864 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
865 DELIRIUM 1 0.0000
866 RASH MACULAR 1 0.0000
867 HYPERKALAEMIA 1 0.0000
868 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
869 C-REACTIVE PROTEIN INCREASED 1 0.0000
870 UNDERDOSE 2 0.0000
871 EPISTAXIS 2 0.0000
872 ASTHMA 3 0.0000
873 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
874 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
875 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
876 RASH 11 0.0000
877 OFF LABEL USE 22 0.0000
878 CARDIAC FAILURE CONGESTIVE 2 0.0000
879 DRUG DEPENDENCE 4 0.0000
880 JOINT SWELLING 3 0.0000
881 DRY MOUTH 2 0.0000
882 OSTEOPOROSIS 1 0.0000
883 CARDIAC ARREST 2 0.0000
884 VISUAL IMPAIRMENT 3 0.0000
885 CARDIO-RESPIRATORY ARREST 1 0.0000
886 WITHDRAWAL SYNDROME 1 0.0000
887 HYPERHIDROSIS 3 0.0000
888 PRODUCT STORAGE ERROR 2 0.0000
889 MUSCULOSKELETAL STIFFNESS 2 0.0000
890 ANGIOEDEMA 1 0.0000
891 PULMONARY OEDEMA 1 0.0000
892 DEVICE ISSUE 2 0.0000
893 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
894 SKIN DISCOLOURATION 1 0.0000
895 DIARRHOEA 14 0.0000
896 BLOOD GLUCOSE INCREASED 4 0.0000
897 DISEASE RECURRENCE 1 0.0000
898 PRODUCTIVE COUGH 1 0.0000
899 CONTUSION 2 0.0000
900 INTERSTITIAL LUNG DISEASE 1 0.0000
901 HYPOGLYCAEMIA 1 0.0000
902 DRY EYE 1 0.0000
903 AGGRESSION 1 0.0000
904 FLUSHING 2 0.0000
905 ERYTHEMA 4 0.0000
906 INFLAMMATION 1 0.0000
907 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
908 MUSCULOSKELETAL PAIN 1 0.0000
909 SPEECH DISORDER 1 0.0000
910 RASH PRURITIC 1 0.0000
911 OEDEMA 1 0.0000
912 ARTHROPATHY 1 0.0000
913 MEDICATION ERROR 1 0.0000
914 PANCYTOPENIA 1 0.0000
915 ABDOMINAL DISCOMFORT 3 0.0000
916 THROMBOCYTOPENIA 2 0.0000
917 HERPES ZOSTER 1 0.0000
918 MYOCARDIAL INFARCTION 3 0.0000
919 NASAL CONGESTION 1 0.0000
920 WHEEZING 1 0.0000
921 CATARACT 1 0.0000
922 THERAPEUTIC RESPONSE DECREASED 1 0.0000
923 PRODUCT USE ISSUE 3 0.0000
924 BLOOD PRESSURE DECREASED 1 0.0000
925 DRY SKIN 2 0.0000
926 HYPOTENSION 3 0.0000
927 NEUTROPENIA 2 0.0000
928 VISION BLURRED 2 0.0000
929 INJURY 1 0.0000
930 OVERDOSE 3 0.0000
931 DYSGEUSIA 1 0.0000
932 ACNE 1 0.0000
933 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
934 DRUG WITHDRAWAL SYNDROME 1 0.0000
935 DYSPHAGIA 1 0.0000
936 HAEMOGLOBIN DECREASED 1 0.0000
937 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
938 DISEASE PROGRESSION 1 0.0000
939 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
940 PSORIASIS 1 0.0000
941 URTICARIA 1 0.0000
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000